← Back to Clinical Trials
Recruiting NCT06600542

NCT06600542 Inari VISION Registry

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06600542
Status Recruiting
Phase
Sponsor Inari Medical
Condition Pulmonary Embolism
Study Type OBSERVATIONAL
Enrollment 1,000 participants
Start Date 2025-03-07
Primary Completion 2029-12-31

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type OBSERVATIONAL
Interventions
Inari Medical Commercially Available Devices

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 1,000 participants in total. It began in 2025-03-07 with a primary completion date of 2029-12-31.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This registry is a global prospective, non-randomized, multicenter, observational, active post-market data collection of Inari Medical devices and products.

Eligibility Criteria

Inclusion Criteria: 1. Willing and able to provide informed consent per institution and geographical requirements 2. Has received treatment with an eligible Inari Medical device. NOTE: If patients are consented prior to their procedure and the procedure does not take place, the patient will be considered a screen failure. 3. Currently within enrollment window relative to their procedure 4. Age ≥ 18 years Exclusion Criteria: 1. Is or will be inaccessible for registry follow-up 2. Meets exclusion criteria required by local requirements 3. Current or planned participation in another drug or device study that, in the investigator's opinion, would interfere with participation in this registry 4. Is pregnant or breastfeeding at the time of enrollment

Contact & Investigator

Central Contact

Ida Nelson

✉ ida.nelson@inarimedical.com

📞 46 707 723010

Frequently Asked Questions

Who can join the NCT06600542 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Pulmonary Embolism. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06600542 currently recruiting?

Yes, NCT06600542 is actively recruiting participants. Contact the research team at ida.nelson@inarimedical.com for enrollment information.

Where is the NCT06600542 trial being conducted?

This trial is being conducted at Ancona, Italy, Lisbon, Portugal, Bristol, United Kingdom, Glasgow, United Kingdom and 6 additional locations.

Who is sponsoring the NCT06600542 clinical trial?

NCT06600542 is sponsored by Inari Medical. The trial plans to enroll 1,000 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology